NCT03692026

Brief Summary

Placing implants immediately after tooth extraction offers several advantages such as preventing bone resorption, maintaining alveolar crest width and height, reducing surgical procedures and treatment time, in addition to good esthetic results. Immediate implant placement after tooth extraction is often associated with a residual gap between the implant surface and the residual bone walls. Osseointegration between the implant surface and the surrounding osseous walls of the extraction socket should increase using materials that promote new bone formation. Since both melatonin and hyaluronic acid are thought to have a positive effect on increasing osseointegration and decreasing inflammation of the tissues; the investigators want to test if adding a mix of hyaluronic acid and melatonin to immediately implant, will give a better implant stability, decreased peri-implant bone loss and decreased post-operative pain versus immediate implant placement without adding any material.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Oct 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2018

Completed
2 days until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 2, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

October 3, 2018

Status Verified

October 1, 2018

Enrollment Period

1.3 years

First QC Date

September 29, 2018

Last Update Submit

October 1, 2018

Conditions

Keywords

post-extraction implant, dental implantmelatoninHyaluronic acid

Outcome Measures

Primary Outcomes (1)

  • Implant stability

    Measuring the implant stability using Ostell device

    six months

Secondary Outcomes (2)

  • Peri-implant horizontal bone changes

    six months

  • post-operative pain

    six months

Study Arms (2)

Study group

EXPERIMENTAL

Immediate implant placement in fresh extraction sockets with addition of Hyaluronic acid and Melatonin mixture to the implant surface, into the extraction socket and to the peri-implant area.

Procedure: Immediate implant placementDrug: Hyaluronic acid and Melatonin Mixture

Control group

ACTIVE COMPARATOR

Immediate implant placement in fresh extraction sockets without adding any material.

Procedure: Immediate implant placement

Interventions

implants will be placed in freshly extraction sockets with or without application of Hyaluronic acid and Melatonin mixture.

Also known as: early implant placement
Control groupStudy group

a mixture of hyaluronic acid and melatonin will be prepared and added topically to the implant surface, extraction socket and peri-implant area for the study group

Study group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old. .single non-restorable teeth in the inter-bicuspid area. .adequate bone volume for the dental implant procedure. .compliant to oral hygiene measures. .accepting to sign an informed consent to undergo the treatment.

You may not qualify if:

  • Heavy smokers. .Systemic disease that contraindicates implant placement or surgical procedures.
  • No or poor patient's compliance.
  • Psychological problems.
  • Periapical pathosis at the site of intervention.
  • Pregnant females.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • de Brito Bezerra B, Mendes Brazao MA, de Campos ML, Casati MZ, Sallum EA, Sallum AW. Association of hyaluronic acid with a collagen scaffold may improve bone healing in critical-size bone defects. Clin Oral Implants Res. 2012 Aug;23(8):938-42. doi: 10.1111/j.1600-0501.2011.02234.x. Epub 2011 Jun 21.

    PMID: 21689163BACKGROUND
  • Botticelli D, Berglundh T, Lindhe J. Hard-tissue alterations following immediate implant placement in extraction sites. J Clin Periodontol. 2004 Oct;31(10):820-8. doi: 10.1111/j.1600-051X.2004.00565.x.

    PMID: 15367183BACKGROUND
  • Swami V, Vijayaraghavan V, Swami V. Current trends to measure implant stability. J Indian Prosthodont Soc. 2016 Apr-Jun;16(2):124-30. doi: 10.4103/0972-4052.176539.

  • El-Gammal MY, Salem AS, Anees MM, Tawfik MA. Clinical and Radiographic Evaluation of Immediate Loaded Dental Implants With Local Application of Melatonin: A Preliminary Randomized Controlled Clinical Trial. J Oral Implantol. 2016 Apr;42(2):119-25. doi: 10.1563/aaid-joi-D-14-00277. Epub 2015 Jun 23.

  • Paolantonio M, Dolci M, Scarano A, d'Archivio D, di Placido G, Tumini V, Piattelli A. Immediate implantation in fresh extraction sockets. A controlled clinical and histological study in man. J Periodontol. 2001 Nov;72(11):1560-71. doi: 10.1902/jop.2001.72.11.1560.

MeSH Terms

Interventions

Hyaluronic Acid

Intervention Hierarchy (Ancestors)

GlycosaminoglycansPolysaccharidesCarbohydrates

Study Officials

  • Mona Darhous, PhD

    Professor of Periodontology. Faculty of Oral and Dental Medicine. Cairo University

    STUDY CHAIR
  • Mona Shoeib, PhD

    Professor of Periodontology. Faculty of Oral and Dental Medicine. Cairo University

    STUDY DIRECTOR
  • Ahmed El Barbary, PhD

    Ass. Professor of Periodontology. Faculty of Oral and Dental Medicine. Cairo University

    STUDY DIRECTOR

Central Study Contacts

Azza M Nasr, MSc

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: It's a Randomized Clinical Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Main investigator

Study Record Dates

First Submitted

September 29, 2018

First Posted

October 2, 2018

Study Start

October 1, 2018

Primary Completion

February 1, 2020

Study Completion

June 1, 2020

Last Updated

October 3, 2018

Record last verified: 2018-10